Delivery Order SPE2DB20D2104-SPE2DB24FR74Q
- Not listed
- This is a $2,377.84 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication, in support of military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides...
- This is a firm fixed-price delivery order for $1,093.20 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a prescription medication. The order is part of a larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,818.62 to AmerisourceBergen Drug Corp for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- This is a $5,939.60 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication, with a period of performance through January 28, 2025. The contract is not designated as a set-aside and was awarded under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,375.44, is for the supply of MICARDIS HCT 80-12.5 MG TABLET UD 30S, a cardiovascular medication. The contract has a firm fixed price and an ultimate completion date of May 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
- This is a $7,024.29 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Micardis HCT 40-12.5 mg tablets in unit doses of 30s. This award is issued under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which covers a comprehensive range of pharmaceutical products and medical supplies to support military...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,449.90 Firm Fixed Price delivery order is for the procurement of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication. This contract is not set aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which enables the efficient procurement of a...
- This is a $4,993.21 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Micardis HCT 80-25 mg tablets, a cardiovascular medication, with a completion date of November 29, 2023. The award is not associated with a set-aside program. In addition to this delivery order, AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,132.43 firm fixed-price contract is for the delivery of MICARDIS HCT 80-12.5 MG TABLET UD 30S, a cardiovascular medication. The award has an ultimate completion date of April 19, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,457.72, is for the supply of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication. The contract is a firm-fixed price delivery order, with a completion date of November 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FR74QDelivery Order
This is a $1,442.40 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, which are prescription cardiovascular medications. The contract has an ultimate completion date of December 21, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 12/20/23 |